Skip to content

Effects of Kinesio Taping and Extracorporeal Shock Wave Therapy in the Calcaneal Spur

Effects of Kinesio Taping Versus Extracorporeal Shock Wave Therapy on Pain in the Treatment of Calcaneal Spur: A Retrospective Clinical Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06533683
Enrollment
60
Registered
2024-08-01
Start date
2023-09-01
Completion date
2024-03-01
Last updated
2024-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Calcaneal Spur, Heel Pain, Plantar Fasciitis

Keywords

calcaneal spur, extracorporeal shock wave therapy, kinesio taping, plantar fasciitis

Brief summary

The term "heel pain" is used to describe a common, painful condition that is localized in the plantar part of the heel and worsens when weight is placed on the heel. Patients with heel pain are more likely to have thickened plantar fascia, abnormal plantar fascia tissue, thicker plantar heel fat pad, and calcaneal spur. Calcaneal spurs are bony protrusions that typically occur just in front of the medial calcaneal tuberosity. Systemic medical treatments, physical therapy agents, exercise and local injections are often applied for heel pain caused by plantar fasciitis and calcaneal spur. This study is to examine the effects of ESWT and kinesio taping on pain and other clinical outcomes in patients with calcaneal spurs.

Detailed description

The responses of patients who underwent ESWT or kinesio taping due to calcaneal spur before and after treatment will be compared. Pain, functionality and quality of life are the clinical parameters compared.

Interventions

None listed

Sponsors

Sisli Hamidiye Etfal Training and Research Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Aged 18 years and over with heel pain * A calcaneal spur seen on foot radiographs

Exclusion criteria

* Those who had received a steroid injection into the heel within the past three months * Those who had experienced trauma or surgery to the foot and ankle within the past six months * Those with a rheumatic disease affecting the foot and ankle (e.g., spondyloarthritis) * Those with open wounds or infections in the area to be treated with lesions.

Design outcomes

Primary

MeasureTime frameDescription
Pain level before treatment and 3rd month after treatmentFrom enrollment to the end of treatment at 3rd monthPain level will be evaluated with the Numerical Rating Scale. (minimum: 0, maximum: 10)

Secondary

MeasureTime frameDescription
Assessment of heel sensitivityFrom enrollment to the end of treatment at 3rd monthIt will be evaluated with the Heel Tenderness index. (0=no pain; 1=painful; 2=painful and whines; 3=painful, whines, and withdraws)
Assessment of functionalityFrom enrollment to the end of treatment at 3rd monthFoot Function Index was used. The FFI consists of 23 items divided into 3 subscales that quantify the impact of foot pathology on pain, disability, and activity limitation in patients. Pain, disability, and activity limitation subscale scores range from 0 to 100.
Assessment of quality of lifeFrom enrollment to the end of treatment at 3rd monthThe 12-item short-form health survey (SF-12) quality of life scale was used to evaluate general quality of life. It was presented as a physical component score (PCS) and mental component score (MCS). Scores range from 0 to 100, with higher scores indicating better physical and mental health functioning.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026